Login or sign up
For business

Xenon Pharmaceuticals

4.1ยท 12 reviews
Average ratingGreat
4.1/ 5

Based on 12 reviews

533%
442%
325%
20%
10%
Ask AI

Ask AI about Xenon Pharmaceuticals

Generated with AI from 12 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Jaime Lau
Reviews 1

I have been using Xenon Pharmaceuticals for a while now and I am extremely satisfied with their products. The website is easy to navigate and the ordering process is simple. The quality of the products is excellent and they always arrive on time. Highly recommend!

Rich Fargnoli
Reviews 1

Xenon Pharmaceuticals is an excellent company. They have a great team and provide top-notch service. I have been a customer for several years and have always been impressed with their products and customer support. The website is user-friendly and easy to navigate. I highly recommend Xenon Pharmaceuticals!

Francesco Venturi
Reviews 1

I recently tried out a new pharmaceutical company and was pleasantly surprised by the quality of their products. The customer support was also excellent, providing quick responses to my inquiries. Overall, I had a great experience and would definitely recommend them.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website โ€” a simple way to convert your visitors into customers.

Get the widget for your site →

About Xenon Pharmaceuticals

XENONยฎ is a biopharmaceutical company focused on the development of novel medicines through the application of our proprietary discovery platform, which we refer to as Extreme Genetics. Our product candidates are based on genetic insights derived from our research of families where individuals exhibit severe traits, or phenotypes. We apply our expertise to predict which phenotypes are caused by single-gene defects. By identifying and characterizing the single-gene defects responsible for such severe phenotypes, we gain valuable insights into their function in human biology and their potential as drug targets. Given that these targets are often involved in diseases beyond the rare genetic disorders in which they are first identified, we are developing proprietary product candidates to treat both orphan as well as more prevalent diseases

Address
3650 Gilmore Way # 200
Categories
Accounting